Cited by 669Virus-based gene therapy researchImmunotherapy and Immune ResponsesSARS-CoV-2 and COVID-19 Research

The DOI matches its Crossref record; 132 of the 134 references it cites were found in a registry or an index.

Adenoviruses as vaccine vectors

Open access

Tatsis, Nia, Ertl, Hildegund C.J.·2004·Molecular Therapy

DOI 10.1016/j.ymthe.2004.07.013PMC PMC7106330

Open this paper in CoChat — free account

Abstract

Adenoviruses have transitioned from tools for gene replacement therapy to bona fide vaccine delivery vehicles. They are attractive vaccine vectors as they induce both innate and adaptive immune responses in mammalian hosts. Currently, adenovirus vectors are being tested as subunit vaccine systems for numerous infectious agents ranging from malaria to HIV-1. Additionally, they are being explored as vaccines against a multitude of tumor-associated antigens. In this review we describe the molecular biology of adenoviruses as well as ways the adenovirus vectors can be manipulated to enhance their efficacy as vaccine carriers. We describe methods of evaluating immune responses to transgene products expressed by adenoviral vectors and discuss data on adenoviral vaccines to a selected number of pathogens. Last, we comment on the limitations of using human adenoviral vectors and provide alternatives to circumvent these problems. This field is growing at an exciting and rapid pace, thus we have limited our scope to the use of adenoviral vectors as vaccines against viral pathogens.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2004.07.013

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“3 , are now available [61] [62] [63] [64] .”
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt‐Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Innate immune recognition: mechanisms and pathways
Medzhitov, R., & Janeway, C. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917309.x · Cited by 1,589
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
Shiver, J. W., Fu, T., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,173
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
Yang, Y., Li, Q., Ertl, H. C. J., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,033
Self-citation
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
TSANG, K. W. T., Ho, P., OOI, G. C., Yee, W. K. S., Wang, T., Chan-Yeung, M. M. W., Lam, W. K., Seto, W., Yam, L. Y.-C., CHEUNG, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,018
CD46 is a cellular receptor for group B adenoviruses
Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003) · Nature Medicine · doi:10.1038/nm952 · Cited by 793
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 655

Flagged first, then by citations

Show all 134 references

2 of the 134 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Fisher, 2000, Protection and retargeting of adenovirus using a multifunctional hydrophilic polymer, Mol. Ther., 1S, 57

Sorted by citations

Items 201–300 of 665

Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy
Bermejo, A. V., Ragonnaud, E., Daradoumis, J., & Holst, P. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144843 · Cited by 39
A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice
Kim, E. R., Weisel, F. J., Balmert, S. C., Khan, M. S., Huang, S., Erdös, G., Kenniston, T. W., Carey, C. D., Joachim, S. M., Conter, L. J., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202149167 · Cited by 40
Heterologous boost vaccines for bacillus Calmette–Guérin prime immunization against tuberculosis
Xing, Z., & Charters, T. J. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.4.539 · Cited by 37
Recombinant adenovirus expressing F and H fusion proteins of peste des petits ruminants virus induces both humoral and cell-mediated immune responses in goats
Wang, Y., Liu, G., Chen, Z., Li, C., Shi, L., Li, W., Huang, H., Tao, C., Cheng, C., Xu, B., et al. (2013) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2013.05.002 · Cited by 37
Advances in CRISPR Delivery Methods: Perspectives and Challenges
Demirci, S., Essawi, K., Germino-Watnick, P., Liu, X., Hakami, W., & Tisdale, J. F. (2022) · The CRISPR Journal · doi:10.1089/crispr.2022.0051 · Cited by 37
Disrupted Adenovirus-Based Vaccines Against Small Addictive Molecules Circumvent Anti-Adenovirus Immunity
De, B. P., Pagovich, O. E., Hicks, M. J., Rosenberg, J. B., Moreno, A. Y., Janda, K. D., Koob, G. F., Worgall, S., Kaminsky, S. M., Sondhi, D., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.163 · Cited by 34
Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
Kim, S., Kim, J., Choi, Y., Nguyen, H. H., Song, M., & Chang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075460 · Cited by 36
Photosensitisation facilitates cross-priming of adjuvant-free protein vaccines and stimulation of tumour-suppressing CD8 T cells
Håkerud, M., Selbo, P. K., Waeckerle‐Men, Y., Contassot, E., Dziunycz, P., Kündig, T. M., Høgset, A., & Johansen, P. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.032 · Cited by 36
Viral Vector Vaccines against Bluetongue Virus
Jiménez-Cabello, L., Utrilla-Trigo, S., Calvo-Pinilla, E., Moreno, S., Nogales, A., Ortego, J., & Marín-López, A. (2020) · Microorganisms · doi:10.3390/microorganisms9010042 · Cited by 39
A CD46-binding Chimpanzee Adenovirus Vector as a Vaccine Carrier
Tatsis, N., Blejer, A., Lasaro, M. O., Hensley, S. E., Cun, A., Tesema, L., Li, Y., Gao, G., Xiang, Z., Zhou, D., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300078 · Cited by 36
Self-citation
Unlocking Genome Editing: Advances and Obstacles in CRISPR/Cas Delivery Technologies
Kaupbayeva, B., Tsoy, A., Safarova, Y., Nurmagambetova, A., Murata, H., Matyjaszewski, K. A., & Askarova, S. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15110324 · Cited by 40
Fusion of HCV Nonstructural Antigen to MHC Class II–associated Invariant Chain Enhances T-cell Responses Induced by Vectored Vaccines in Nonhuman Primates
Capone, S., Naddeo, M., D’Alise, A. M., Abbate, A., Grazioli, F., Gaudio, A. D., Sorbo, M. D., Esposito, M. L., Ammendola, V., Perretta, G., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.15 · Cited by 35
Intranasal Adenovirus-Vectored Vaccine for Induction of Long-Lasting Humoral Immunity-Mediated Broad Protection against Influenza in Mice
Kim, E. H., Park, H.-J., Han, G.-Y., Song, M., Pereboev, A. V., Hong, J. S., Chang, J., Byun, Y.-H., Seong, B. L., & Nguyen, H. H. (2014) · Journal of Virology · doi:10.1128/jvi.00823-14 · Cited by 35
Drugs in Development for Hepatitis B
Dawood, A., Basit, S. A., Jayaraj, M., & Gish, R. G. (2017) · Drugs · doi:10.1007/s40265-017-0769-2 · Cited by 35
Cytokine Response and Survival of Mice Immunized with an Adenovirus Expressing Bacillus anthracis Protective Antigen Domain 4
McConnell, M. J., Hanna, P. C., & Imperiale, M. J. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1009-1015.2006 · Cited by 35
Genetic engineering of a modified herpes simplex virus 1 vaccine vector
Liu, X., Broberg, E., Watanabe, D., Dudek, T. E., DeLuca, N. A., & Knipe, D. M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.003 · Cited by 35
Adenoviral Vector COVID-19 Vaccines: Process and Cost Analysis
Ferreira, R. G., Gordon, N. F., Stock, R., & Petrides, D. P. (2021) · Processes · doi:10.3390/pr9081430 · Cited by 36
Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF
Krause, A., Whu, W. Z., Xu, Y., Joh, J., Crystal, R. G., & Worgall, S. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.087 · Cited by 34
Cancer immunotherapy: a paradigm shift for prostate cancer treatment
Karan, D., Holzbeierlein, J. M., Veldhuizen, P. J. V., & Thrasher, J. B. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.106 · Cited by 34
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
Okuyama, R. (2023) · Vaccines · doi:10.3390/vaccines11121737 · Cited by 38
Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses
Grant-Klein, R. J., Altamura, L. A., & Schmaljohn, C. S. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.005 · Cited by 35
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
Zhan, W., Muhuri, M., Tai, P. W. L., & Gao, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673699 · Cited by 35
The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species
Dicks, M. D. J., Guzman, E., Spencer, A. J., Gilbert, S. C., Charleston, B., Hill, A. V. S., & Cottingham, M. G. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.042 · Cited by 33
Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine
Wu, J., Barabé, N. D., Chau, D., Wong, C., Rayner, G. A., Hu, W., & Nagata, L. P. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.042 · Cited by 33
Rapid Vaccination Using an Acetalated Dextran Microparticulate Subunit Vaccine Confers Protection Against Triplicate Challenge by Bacillus Anthracis
Schully, K. L., Sharma, S., Peine, K. J., Pesce, J. T., Elberson, M. A., Fonseca, M. E., Prouty, A. M., Bell, M. G., Borteh, H. M., Gallovic, M. D., et al. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-0975-x · Cited by 33
Protective Immunity Against a Lethal Respiratory Yersinia pestis Challenge Induced by V Antigen or the F1 Capsular Antigen Incorporated into Adenovirus Capsid
Boyer, J. L., Sofer-Podesta, C., Ang, J., Hackett, N. R., Chiuchiolo, M. J., Senina, S., Perlin, D. S., & Crystal, R. G. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.148 · Cited by 33
Optimizing vaccine-induced CD8+T-cell immunity: focus on recombinant adenovirus vectors
Bassett, J. D., Swift, S. L., & Bramson, J. L. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.88 · Cited by 34
An Old Acquaintance: Could Adenoviruses Be Our Next Pandemic Threat?
Saint-Pierre, G., Conei, D., Lizama, L., Zuñiga, D. V., Carvajal, L. F. A., & Ampuero, S. (2023) · Viruses · doi:10.3390/v15020330 · Cited by 34
Immune Responses Induced by Replication-Defective Adenovirus Expressing the C-Terminal Portion of theMycoplasma hyopneumoniaeP97 Adhesin
Okamba, F. R., Moreau, E., Bouh, K. C. S., Gagnon, C. A., Bernard Massie, B., & Arella, M. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00415-06 · Cited by 32
Viral vector vaccines make memory T cells against malaria
Reyes‐Sandoval, A., Harty, J. T., & Todryk, S. M. (2007) · Immunology · doi:10.1111/j.1365-2567.2006.02552.x · Cited by 31
Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Aβ1–6: Toward safer and effective vaccines against Alzheimer’s disease
Kim, H., Maxwell, J. A., Kong, F.-K., Tang, D.-C. C., & Fukuchi, K.-I. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.044 · Cited by 32
Development of a Novel Avian Vaccine Vector Derived From the Emerging Fowl Adenovirus 4
Pan, Q., Zhang, Y., Liu, A., Cui, H., Gao, Y., Qi, X., Liu, C., Zhang, Y., Li, K., Gao, L., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.780978 · Cited by 31
ADENOVIRUS BASED VACCINES GENERATE CYTOTOXIC T LYMPHOCYTES TO EPITOPES OF NS1 FROM DENGUE VIRUS THAT ARE PRESENT IN ALL MAJOR SEROTYPES
Gao, G., Wang, Q., Dai, Z., Calcedo, R., Sun, X., Li, G., & Wilson, J. M. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.011 · Cited by 35
Circumventing Antivector Immunity by Using Adenovirus-Infected Blood Cells for Repeated Application of Adenovirus-Vectored Vaccines: Proof of Concept in Rhesus Macaques
Sun, C., Feng, L., Zhang, Y., Xiao, L., Pan, W., Li, C., Zhang, L., & Chen, L. (2012) · Journal of Virology · doi:10.1128/jvi.00783-12 · Cited by 31
Therapeutic vaccination against chronic hepatitis C virus infection
Ip, P. P., Nijman, H. W., Wilschut, J., & Daemen, T. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.07.006 · Cited by 32
Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity
Negri, D. R. M., Michelini, Z., Bona, R., Blasi, M., Filati, P., Leone, P., Rossi, A., Franco, M., & Cara, A. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.571670 · Cited by 32
Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope
García-Moure, M., Martínez-Vélez, N., Patiño‐García, A., & Alonso, M. M. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.12.001 · Cited by 30
Avian CD154 enhances humoral and cellular immune responses induced by an adenovirus vector-based vaccine in chickens
Sánchez, O., González, A., Gómez-Puerta, S., Gómez, J., Redondo, A. V., Benites, J. C. Á., Suárez-Amarán, L., Parra, N. C., & Toledo, J. R. (2010) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2010.12.001 · Cited by 30
Respiratory mucosal immunization with adenovirus gene transfer vector induces helper CD4 T cell‐independent protective immunity
Mu, J., Jeyanathan, M., Shaler, C. R., Horvath, C. N., Damjanovic, D., Zganiacz, A., Kugathasan, K., McCormick, S. M., & Xing, Z. (2010) · The Journal of Gene Medicine · doi:10.1002/jgm.1487 · Cited by 30
A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer
Riezebos‐Brilman, A., Walczak, M., Regts, J., Rots, M. G., Kamps, G., Dontje, B., Haisma, H. J., Wilschut, J., & Daemen, T. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303036 · Cited by 30
Efficient replication and generation of recombinant bovine adenovirus‐3 in nonbovine cotton rat lung cells expressing I‐SceI endonuclease
Du, E., & Tikoo, S. K. (2010) · The Journal of Gene Medicine · doi:10.1002/jgm.1505 · Cited by 30
An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity
Hartman, Z. C., Wei, J.-P., Osada, T., Glass, O., Lei, G., Yang, X.-Y., Peplinski, S., Kim, D., Xia, W., Spector, N. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2549 · Cited by 30
A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates
Sha, J., Kirtley, M. L., Klages, C., Erova, T. E., Telepnev, M. V., Ponnusamy, D., Fitts, E. C., Baze, W. B., Sivasubramani, S. K., Lawrence, W. S., et al. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00150-16 · Cited by 30
Overcoming the Delivery Challenges in CRISPR/Cas9 Gene Editing for Effective Cancer Treatment: A Review of Delivery Systems
Tang, S., Chen, X., Tong, X., & Zhu, L. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.112724 · Cited by 31
The influence of delivery vectors on HIV vaccine efficacy
Ondondo, B. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00439 · Cited by 29
Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine
Segundo, F. D.-S., Dias, C. C. A., Moraes, M. P., Weiss, M., Pérez-Martín, E., Salazar, A. Μ., Grubman, M. J., & Santos, T. D. L. (2014) · Virology · doi:10.1016/j.virol.2014.08.012 · Cited by 29
Adenovirus-Based Vaccine against Listeria monocytogenes: Extending the Concept of Invariant Chain Linkage
Jensen, S. B., Steffensen, M. A., Jensen, B. A. H., Schlüter, D., Christensen, J. P., & Thomsen, A. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301290 · Cited by 29
An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery
Madani, F., Hsein, H., Busignies, V., & Tchoreloff, P. (2019) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2019.1689402 · Cited by 29
Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production
Müller, M. K., Volzke, J., Subin, B., Müller, S. C., Sombetzki, M., Reisinger, E. C., & Müller‐Hilke, B. (2022) · BMC Medicine · doi:10.1186/s12916-022-02240-4 · Cited by 27
T-cell immunity generated by recombinant adenovirus vaccines
Yang, T. C., Millar, J., Grinshtein, N., Bassett, J. D., Finn, J. D., & Bramson, J. L. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.347 · Cited by 29
A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)HXB2 Rev/Env or codon-optimized HIV-1JR-FL gp120 generates durable immune responses in mice
Buffa, V., Negri, D. R. M., Leone, P., Bona, R., Borghi, M., Bacigalupo, I., Carlei, D., Sgadari, C., Ensoli, B., & Cara, A. (2006) · Journal of General Virology · doi:10.1099/vir.0.81706-0 · Cited by 28
Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus
Lee, S.-Y., Kang, J.-O., & Chang, J. (2019) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2019.8.1.54 · Cited by 29
The interactions between PML nuclear bodies and small and medium size DNA viruses
Ryabchenko, B., Šroller, V., Horníková, L., Lovtsov, A., Forstová, J., & Huérfano, S. (2023) · Virology Journal · doi:10.1186/s12985-023-02049-4 · Cited by 31
Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus
Barabé, N. D., Rayner, G. A., Christopher, M. E., Nagata, L. P., & Wu, J. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.054 · Cited by 28
Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
Günl, F., Mecate-Zambrano, A., Rehländer, S., Hinse, S., Ludwig, S., & Brunotte, L. (2021) · Vaccines · doi:10.3390/vaccines9101052 · Cited by 27
Recombinant adenoviral vaccine encoding the spike 1 subunit of the Middle East Respiratory Syndrome Coronavirus elicits strong humoral and cellular immune responses in mice
Ababneh, M. M. K., Alrwashdeh, M., & Khalifeh, M. (2019) · Veterinary World · doi:10.14202/vetworld.2019.1554-1562 · Cited by 26
Elimination of the hepatitis B virus: A goal, a challenge
Pondé, R. A. D. A., & Amorim, G. D. S. P. (2024) · Medicinal Research Reviews · doi:10.1002/med.22030 · Cited by 28
Evaluation of Different Strategies for Post-Exposure Treatment of Ebola Virus Infection in Rodents
Wong, G., Richardson, J. S., & Pillet, S. (2011) · Journal of Bioterrorism & Biodefense · doi:10.4172/2157-2526.s1-007 · Cited by 25
Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus
Utrilla-Trigo, S., Jiménez-Cabello, L., Alonso-Ravelo, R., Calvo-Pinilla, E., Marín-López, A., Moreno, S., Lorenzo, G., Benavides, J., Gilbert, S. C., Nogales, A., et al. (2020) · Vaccines · doi:10.3390/vaccines8030346 · Cited by 26
Antibody Responses against Xenotropic Murine Leukemia Virus-Related Virus Envelope in a Murine Model
Makarova, N., Zhao, C., Zhang, Y., Bhosle, S. M., Suppiah, S., Rhea, J. M., Kozyr, N. L., Arnold, R. S., Ly, H., Molinaro, R. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018272 · Cited by 27
Imaging Gene Delivery with Fluorescence Microscopy
Payne, C. K. (2007) · Nanomedicine · doi:10.2217/17435889.2.6.847 · Cited by 27
Antibody-Dependent Natural Killer Cell–Mediated Cytotoxicity Engendered by a Kinase-Inactive Human HER2 Adenovirus-Based Vaccination Mediates Resistance to Breast Tumors
Triulzi, C., Vertuani, S., Curcio, C., Antognoli, A., Seibt, J., Akusjärvi, G., Wei, W., Cavallo, F., & Kiessling, R. W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0493 · Cited by 27
Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes
Hjálmsdóttir, Á., Bühler, C., Vonwil, V., Roveri, M., Håkerud, M., Waeckerle‐Men, Y., Gander, B. A., & Johansen, P. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00394 · Cited by 27
A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates
Liu, H., Liu, X., Li, S., Wu, B., Ye, L., Wang, Q., & Chen, Z. (2009) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2009.01.004 · Cited by 27
Therapeutic Effect of Recombinant Adenovirus Encoding Interferon-γ in a Murine Model of Progressive Pulmonary Tuberculosis
Mata‐Espinosa, D., Mendoza-Rodríguez, V., Aguilar‐León, D., Rosales, R., López‐Casillas, F., & Hernández‐Pando, R. (2008) · Molecular Therapy · doi:10.1038/mt.2008.69 · Cited by 27
Bacterial Nanocompartments: Structures, Functions, and Applications
McDowell, H. B., & Hoiczyk, E. (2021) · Journal of Bacteriology · doi:10.1128/jb.00346-21 · Cited by 26
Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice
Zhao, Z., Deng, X., Jia, J., Zhao, L., Wang, C., Cai, Z., Guo, C. Y., Yang, L., Wang, D., Ma, S., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154921 · Cited by 26
Viral Vectors, Exosomes, and Vexosomes: Potential armamentarium for delivering CRISPR/Cas to cancer cells
Farzanehpour, M., Miri, A., Alvanegh, A. G., & Gouvarchinghaleh, H. E. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115555 · Cited by 27
Viral vector‐based cancer treatment and current clinical applications
Xie, L., Han, Y., Liu, Y., Zhou, Y., Yu, J., von Brunn, A., & Lei, J. (2023) · MedComm – Oncology · doi:10.1002/mog2.55 · Cited by 28
Adenovirus Type 4 and 7 Vaccination or Adenovirus Type 4 Respiratory Infection Elicits Minimal Cross-Reactive Antibody Responses to Nonhuman Adenovirus Vaccine Vectors
Paris, R., Kuschner, R. A., Binn, L. N., Thomas, S. J., Colloca, S., Nicosia, A., Cortese, R., Bailer, R. T., Sullivan, N. J., & Koup, R. A. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00011-14 · Cited by 26
Research progress of therapeutic vaccines for treating chronic hepatitis B
Li, J., Bao, M., Ge, J., Ren, S., Zhou, T., Feng-chun, Q., Pu, X., & Dou, J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1276125 · Cited by 26
COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations
Shu, H., Zheng, W., Li, N., Zhang, Z., Ceesay, B. M., Peng, Y., Zhou, N., & Wang, D. W. (2023) · Aging and Disease · doi:10.14336/ad.2023.0314 · Cited by 25
Multiple antigen presenting system (MAPS): state of the art and potential applications
Malley, R., Lu, Y., Sebastian, S., Zhang, F., & Willer, D. O. (2024) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2299384 · Cited by 25
A modern approach for epitope prediction: identification of foot-and-mouth disease virus peptides binding bovine leukocyte antigen (BoLA) class I molecules
Pandya, M., Rasmussen, M., Hansen, A., Nielsen, M., Buus, S., Golde, W. T., & Barlow, J. (2015) · Immunogenetics · doi:10.1007/s00251-015-0877-7 · Cited by 25
Evaluation of Novel Large Cut-Off Ultrafiltration Membranes for Adenovirus Serotype 5 (Ad5) Concentration
Nestola, P., Martins, D. L., Peixoto, C., Roederstein, S., Schleuß, T., Alves, P. M., Mota, J. P. B., & Carrondo, M. J. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115802 · Cited by 25
Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses
Powers, J. M., Haese, N. N., Denton, M. C., Ando, T., Kreklywich, C. N., Bonin, K., Streblow, C. E., Kreklywich, N., Smith, P. P., Broeckel, R. M., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009308 · Cited by 25
Polymer-Functionalized Nanoparticles: From Stealth Viruses to Biocompatible Quantum Dots
Jia, H., & Titmuss, S. (2009) · Nanomedicine · doi:10.2217/nnm.09.81 · Cited by 25
Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection
Lu, M., Yao, Y., Liu, H., Zhang, X., Li, X., Liu, Y., Peng, Y., Chen, T., Sun, Y., Gao, G., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.175461 · Cited by 24
AAV-Based Gene Therapy: Opportunities, Risks, and Scale-Up Strategies
Moldavskii, D., Gilazieva, Z., Fattakhova, А. N., Solovyeva, V. V., Issa, S. S., Sufianov, A. A., Суфианова, Г. З., & Rizvanov, A. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178282 · Cited by 28
Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma
Yang, H., Hu, B., Xiao, L., & Wang, P. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.13 · Cited by 24
A New Look at Vaccine Strategies Against PPRV Focused on Adenoviral Candidates
Rojas, J. M., Sevilla, N., & Martı́n, V. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.729879 · Cited by 27
Novel vaccination approaches against equine alphavirus encephalitides
Carossino, M., Thiry, É., de la Grandière, A., & Barrandeguy, M. E. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.11.071 · Cited by 24
Rational development of two flowthrough purification strategies for adenovirus type 5 and retro virus-like particles
Nestola, P., Peixoto, C., Villain, L., Alves, P. M., Carrondo, M. J. T., & Mota, J. P. B. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.11.037 · Cited by 24
DNA vaccination for prostate cancer: key concepts and considerations
Cole, G., McCaffrey, J., Ali, A., & McCarthy, H. O. (2015) · Cancer Nanotechnology · doi:10.1186/s12645-015-0010-5 · Cited by 24
Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in micePreprint
Polak, K., Greze, N., Lachat, M., Merle, D., Chiumento, S., Bertrand‐Gaday, C., Trentin, B., & Mamoun, R. Z. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.28.357137 · Cited by 24
Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
Scarsella, L., Ehrke‐Schulz, E., Paulussen, M., Thal, S. C., Ehrhardt, A., & Aydin, M. (2024) · Viruses · doi:10.3390/v16030377 · Cited by 25
COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines
Biswas, B. K., Chattopadhyay, S., Hazra, S., Hansda, A. K., & Goswami, R. (2022) · Inflammation Research · doi:10.1007/s00011-022-01555-5 · Cited by 25
Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses
Vujadinovic, M., Khan, S., Oosterhuis, K., Uil, T. G., Wunderlich, K., Damman, S., Boedhoe, S., Verwilligen, A., Knibbe, J., Serroyen, J., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.024 · Cited by 23
An alphavirus-based therapeutic cancer vaccine: from design to clinical trial
Singh, A. D., Koutsoumpli, G., van de Wall, S., & Daemen, T. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2276-z · Cited by 23
Therapeutic Vaccination in Chronic Hepatitis B: Preclinical Studies in the Woodchuck
Kosinska, A. D., Zhang, E., Lu, M., & Roggendorf, M. (2010) · Hepatitis Research and Treatment · doi:10.1155/2010/817580 · Cited by 23
Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform
Luo, J., Mo, F., Zhang, Z., Hong, W., Lan, T., Cheng, Y., Fang, C., Bi, Z., Qin, F., Yang, H. J., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01203-4 · Cited by 25
Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge
Zhang, H., Tang, X., Zhu, C., Song, Y., Yin, J., Xu, J., Ertl, H. C. J., & Zhou, D. (2015) · Gene Therapy · doi:10.1038/gt.2015.31 · Cited by 22
Self-citation
Dendritic Cell-Mediated-Immunization with Xenogenic PrP and Adenoviral Vectors Breaks Tolerance and Prolongs Mice Survival against Experimental Scrapie
Bruley-Rosset, M., Sacquin, A., Lecollinet, S., Chaigneau, T., Adam, M., Crespeau, F., & Éloit, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004917 · Cited by 22
Overview of approved and upcoming vaccines for SARS-CoV-2: a living review
Alderson, J., Batchelor, V., O’Hanlon, M., Cifuentes, L., Richter, F. C., & Kopycinski, J. T. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab010 · Cited by 22
COVID-19 Vaccine: Between Myth and Truth
Piccaluga, P. P., Guardo, A. D., Lagni, A., Lotti, V., Diani, E., Navari, M., & Gibellini, D. (2022) · Vaccines · doi:10.3390/vaccines10030349 · Cited by 22
Anti-adenovirus humoral responses influence on the efficacy of vaccines based on epitope display on adenovirus capsid
Lanzi, A., Youssef, G. B., Perricaudet, M., & Benihoud, K. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.12.025 · Cited by 22
13C‐metabolic flux analysis of human adenovirus infection: Implications for viral vector production
Carinhas, N., Koshkin, A., Pais, D. A. M., Alves, P. M., & Teixeira, A. P. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26063 · Cited by 22
Biosecurity risks associated with vaccine platform technologies
Sandbrink, J. B., & Koblentz, G. D. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.02.023 · Cited by 26
Manufacturing of Adenovirus Vectors: Production and Purification of Helper Dependent Adenovirus
Dormond, E., & Kamen, A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-095-9_6 · Cited by 22
High‐capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product‐directed CD8 T‐cell responses
Kron, M. W., Engler, T., Schmidt, E., Schirmbeck, R., Kochanek, S., & Kreppel, F. (2011) · The Journal of Gene Medicine · doi:10.1002/jgm.1629 · Cited by 22

Authors: Tatsis, N., & Ertl, H. C. J.
Affiliations: The Wistar Institute (US)
Corresponding author: Ertl, Hildegund C.J.
ORCID: Ertl, Hildegund C.J.
Venue: Molecular Therapy
Publisher: Elsevier BV
Published: 2004-10
Volume: 10
Issue: 4
Pages: 616-629
ISSN: 1525-0016 (ISSN-L)
DOI: 10.1016/j.ymthe.2004.07.013
PMC: PMC7106330
OpenAlex: W1972258033
Cited by: 669
References: 134
Citations by year: 2026: 16 · 2025: 28 · 2024: 31 · 2023: 60 · 2022: 58 · 2021: 69 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 20 · 2016: 26 · 2015: 24 · 2014: 21 · 2013: 28 · 2012: 23
FWCI: 3.15
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4389 d)
Locations: Molecular Therapy (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords: adenoviral vector, vaccine vectors, subunit vaccine, viral vaccines, innate immune response, adaptive immune response, transgene expression, HIV-1 vaccine, malaria vaccine, tumor-associated antigens
MeSH terms: Adenoviridae, Adenoviridae Infections, Genes, Viral, Genetic Vectors, Humans, Peptides, Viral Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adenoviruses as vaccine vectors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks